Trazimera
- Product NDC
- 0069-0308
- 11-digit product format
- 000690308
- Labeler code
- 0069
- Product ID
- 0069-0308_6bb3d11b-6f9e-408c-a957-b7bacaf9e175
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- trastuzumab-qyyp
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Application
- BLA761081
- Marketing category
- BLA
- Marketing start
- 2021-03-10
- Substance
- TRASTUZUMAB
- Active strength
- 150 mg/7.15mL
- Pharmacologic classes
- HER2/Neu/cerbB2 Antagonists [MoA], HER2/neu Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| P188ANX8CK | TRASTUZUMAB | 180288-69-1 | TRASTUZUMAB |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0069-0308-01 | 00069030801 | 1 VIAL in 1 CARTON (0069-0308-01) / 7.15 mL in 1 VIAL | 1 vial | 2021-03-10 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Trazimera | Pfizer Laboratories Div Pfizer Inc | Pfizer Ireland Pharmaceuticals Unlimited Company | Pfizer Manufacturing Belgium NV | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 2026-04-10 | HUMAN PRESCRIPTION DRUG LABEL | 9 |